Shan Wu
Corporate Officer/Principal presso VIRIDIAN THERAPEUTICS, INC.
Posizioni attive di Shan Wu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 | - |
Storia della carriera di Shan Wu
Precedenti posizioni note di Shan Wu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Contatto Relazioni con gli Investitori | 01/10/2021 | 01/09/2023 |
| Corporate Officer/Principal | 01/10/2021 | 01/09/2023 |
Formazione di Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Shan Wu
- Esperienza